Cargando…
Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry
OBJECTIVE: To describe clinical features associated with cancer outcomes of patients with immune checkpoint inhibitor (ICI)‐associated arthritis. METHODS: Observational study of patients with ICI‐arthritis enrolled in a single‐center registry. Arthritis phenotype and activity, medications, and cance...
Autores principales: | Chan, Karmela Kim, Tirpack, Aidan, Vitone, Gregory, Benson, Caroline, Nguyen, Joseph, Ghosh, Nilasha, Jannat‐Khah, Deanna, Bykerk, Vivian, Bass, Anne R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571396/ https://www.ncbi.nlm.nih.gov/pubmed/33010198 http://dx.doi.org/10.1002/acr2.11181 |
Ejemplares similares
-
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
por: Ghosh, Nilasha, et al.
Publicado: (2022) -
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey
por: Ghosh, Nilasha, et al.
Publicado: (2020) -
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’ are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis
por: Ghosh, Nilasha, et al.
Publicado: (2023) -
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
por: Barbhaiya, Medha, et al.
Publicado: (2021) -
Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives
por: Chan, Karmela K, et al.
Publicado: (2022)